Echinomycin
SIGMA/SML0477 - ≥98% (HPLC)
Synonym: N-
CAS Number: 512-64-1
Empirical Formula (Hill Notation): C51H64N12O12S2
Molecular Weight: 1101.26
Linear Formula: C51H64N12O12S2
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C51H64N12O12S2/c1-25(2 |
| InChI key | AUJXLBOHYWTPFV-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| shipped in | dry ice |
| SMILES string | S1C(C2N(C(=O)C(NC(=O)C(CO |
| storage condition | desiccated |
| storage temp. | −20°C |
| Application: | Echinomycin has been used for inhibition of hypoxia-inducible factor 1. |
| Biochem/physiol Actions: | Echinomycin is an antitumor antibiotic and potent hypoxia inducible factor 1α (HIF-1α) inhibitor. |
| Biochem/physiol Actions: | Echinomycin is an antitumor antibiotic and potent hypoxia inducible factor 1α (HIF-1α) inhibitor. It binds to DNA via bifunctional intercalation, blocking the binding of HIF-1α, a transcription factor important in tumor growth. Echinomycin selectively eliminated cancer stem cells in a study with mouse lymphoma and human AML xenogeneic models, eradicating the lymphomas. Recently, echinomycin was also found to act as an antibiotic adjuvant having synergistic effects with novobiocin in gram negative bacteria. |
| Packaging: | 1, 5 mg in glass bottle |
| Symbol | ![]() GHS06,GHS08 |
| Signal word | Danger |
| Hazard statements | H301 + H311 + H331 - H361 |
| Precautionary statements | P201 - P280 - P301 + P310 + P330 - P302 + P352 + P312 - P304 + P340 + P311 |
| Hazard Codes | T |
| Risk Statements | 46-23/24/25 |
| Safety Statements | 53-36/37/39-45 |
| RIDADR | UN 3462 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |



